James H. Moffett

Sertoli Technologies, Inc. provides medical services. It develops products to treat insulin-dependent diabetes and hemophilia. The company technology enables treatment of life-threatening diseases caused by a patient's impaired ability to produce a protein, such as insulin in diabetes or factor XIII in hemophilia. Sertoli Technologies was founded in 1996 and is headquartered in Tucson, AZ.

New York Life Insurance Co. engages in the provision of insurance products and services. It offers life insurance, retirement income, long term care, investments, and premier services. The company was founded on April 12, 1845 and is headquartered in New York, NY.

Ashland LLC engages in the manufacture and distribution of specialty chemical solutions. It operates through the following segment: Specialty Ingredients, Composites, and Intermediates and Solvents. The Specialty Ingredients segment offers cellulose ethers, vinyl pyrrolidones, and bifunctional. The Composites segment includes unsaturated polyester resins, vinyl ester resins, and gelcoats. The Intermediates and Solvents segment produces butanediol (BDO) and related derivatives, including tetrahydrofuran and n-methylpyrrolidone. The company was founded by Paul G. Blazer in 1924 and is headquartered in Covington, KY.